Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PARENT.DRUGS vs GLAND PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PARENT.DRUGS GLAND PHARMA PARENT.DRUGS/
GLAND PHARMA
 
P/E (TTM) x -0.1 42.3 - View Chart
P/BV x - 3.4 - View Chart
Dividend Yield % 0.0 1.1 -  

Financials

 PARENT.DRUGS   GLAND PHARMA
EQUITY SHARE DATA
    PARENT.DRUGS
Mar-21
GLAND PHARMA
Mar-24
PARENT.DRUGS/
GLAND PHARMA
5-Yr Chart
Click to enlarge
High Rs32,196 0.1%   
Low Rs3862 0.3%   
Sales per share (Unadj.) Rs4.1343.9 1.2%  
Earnings per share (Unadj.) Rs-40.846.9 -87.0%  
Cash flow per share (Unadj.) Rs-35.067.8 -51.6%  
Dividends per share (Unadj.) Rs020.00 0.0%  
Avg Dividend yield %01.3 0.0%  
Book value per share (Unadj.) Rs-229.0529.6 -43.2%  
Shares outstanding (eoy) m29.82164.71 18.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.74.4 15.9%   
Avg P/E ratio x-0.132.6 -0.2%  
P/CF ratio (eoy) x-0.122.5 -0.4%  
Price / Book Value ratio x02.9 -0.4%  
Dividend payout %042.6 -0.0%   
Avg Mkt Cap Rs m86251,781 0.0%   
No. of employees `000NANA-   
Total wages/salary Rs m14512,569 1.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m12256,647 0.2%  
Other income Rs m11,702 0.0%   
Total revenues Rs m12258,350 0.2%   
Gross profit Rs m-11813,331 -0.9%  
Depreciation Rs m1733,446 5.0%   
Interest Rs m1,254262 478.8%   
Profit before tax Rs m-1,54511,325 -13.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-3283,601 -9.1%   
Profit after tax Rs m-1,2177,725 -15.8%  
Gross profit margin %-96.823.5 -411.1%  
Effective tax rate %21.231.8 66.7%   
Net profit margin %-1,000.313.6 -7,335.3%  
BALANCE SHEET DATA
Current assets Rs m68156,452 1.2%   
Current liabilities Rs m11,43613,984 81.8%   
Net working cap to sales %-8,839.375.0 -11,790.6%  
Current ratio x0.14.0 1.5%  
Inventory Days Days37550 744.2%  
Debtors Days Days0100 0.0%  
Net fixed assets Rs m3,34349,657 6.7%   
Share capital Rs m298165 181.0%   
"Free" reserves Rs m-7,12787,060 -8.2%   
Net worth Rs m-6,82987,225 -7.8%   
Long term debt Rs m1,0721,065 100.6%   
Total assets Rs m4,024106,108 3.8%  
Interest coverage x-0.244.2 -0.5%   
Debt to equity ratio x-0.20 -1,285.2%  
Sales to assets ratio x00.5 5.7%   
Return on assets %0.97.5 12.3%  
Return on equity %17.88.9 201.3%  
Return on capital %5.013.1 38.4%  
Exports to sales %063.1 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA35,764 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m035,764 0.0%   
Fx outflow Rs m09,401 0.0%   
Net fx Rs m026,363 0.0%   
CASH FLOW
From Operations Rs m1,2539,968 12.6%  
From Investments Rs m1-17,569 -0.0%  
From Financial Activity Rs m-1,254-7,994 15.7%  
Net Cashflow Rs m-1-15,518 0.0%  

Share Holding

Indian Promoters % 73.3 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 0.0 39.8 0.0%  
FIIs % 0.0 4.5 -  
ADR/GDR % 0.0 0.0 -  
Free float % 26.7 48.2 55.4%  
Shareholders   7,129 122,358 5.8%  
Pledged promoter(s) holding % 94.5 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PARENT.DRUGS With:   CIPLA    DIVIS LABORATORIES    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on PARENT.DRUGS vs GLAND PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

PARENT.DRUGS vs GLAND PHARMA Share Price Performance

Period PARENT.DRUGS GLAND PHARMA S&P BSE HEALTHCARE
1-Day 4.63% 1.11% 0.97%
1-Month 9.71% 10.58% 1.29%
1-Year -19.48% -0.45% 46.30%
3-Year CAGR 8.97% -20.60% 19.65%
5-Year CAGR -19.84% -0.49% 26.13%

* Compound Annual Growth Rate

Here are more details on the PARENT.DRUGS share price and the GLAND PHARMA share price.

Moving on to shareholding structures...

The promoters of PARENT.DRUGS hold a 73.3% stake in the company. In case of GLAND PHARMA the stake stands at 51.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of PARENT.DRUGS and the shareholding pattern of GLAND PHARMA.

Finally, a word on dividends...

In the most recent financial year, PARENT.DRUGS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

GLAND PHARMA paid Rs 20.0, and its dividend payout ratio stood at 42.6%.

You may visit here to review the dividend history of PARENT.DRUGS, and the dividend history of GLAND PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 993 Points | Nifty Above 24,200 | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 993 Points | Nifty Above 24,200 | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.